DARE BIOSCIENCE INC (DARE) Stock Income Statement
NASDAQ:DARE - Nasdaq - US23666P2002 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.80K | 2.81M | 10.00M | 0.00 | 0.00 | |||
| Operating Expenses | 23.46M | 33.75M | 41.39M | 39.07M | 27.40M | |||
| Research and Development | 14.21M | 21.54M | 30.04M | 30.62M | 20.77M | |||
| Selling, General, and Administrative Expenses | 9.26M | 12.21M | 11.34M | 8.45M | 6.63M | |||
| Operating Income | -23.45M | -30.94M | -31.39M | -39.07M | -27.40M | |||
| Interest Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Other Income/Expense | -381.50K | 778.50K | 440.00K | 0.00 | 0.00 | |||
| Non Recurring Items | 20.38M | N/A | 0.00 | 370.00K | N/A | |||
| Income Before Taxes | -4.05M | -30.16M | -30.95M | -38.70M | -27.40M | |||
| Income Tax | 0.00 | N/A | N/A | N/A | N/A | |||
| Net Income | -4.05M | -30.16M | -30.95M | -38.70M | -27.41M | |||
| EBITDA | -23.41M | -30.90M | -31.37M | -39.04M | -27.36M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.48 | -4.15 | -0.37 | -0.63 | -0.91 | |||
| Non GAAP EPS | -0.52 | -4.08 | -4.44 | -8.52 | -11.64 | |||
| Statistics | ||||||||
| Profit Margin | -41363.27% | -1074.16% | -309.50% | N/A | N/A | |||
| Operating Profit Margin | -239301.02% | -1101.89% | -313.90% | N/A | N/A | |||
All data in USD